In line with this, CD20-TCB treatment of human T cell-WSU DLCL2 co-cultures leads to increased levels of many cytokines and chemokines including CXCL10, most likely by both tumor cells and T cells (Fig 5d and [7]). The gene discussed is CXCL10; the disease is neoplasm.